- Supported exchanges /
- F /
- 76D.F
MEDESIS PHARMA SA EO 2- (76D F) stock market data APIs
Medesis Pharma S.A. operates as a biopharmaceutical company. The company's products include NanoLithium (NP03) for the treatment of Alzheimer's disease; NanosiRNA HD and NanoP42T to treat Huntington's disease; NanoLithium for the prevention and treatment of psychiatric disorders; NanoManganese (NP02), a radiation protection drug; and NU01 plutonium decorporation and NU02 cesium decorporation nuclear drugs. It also develops oncology drugs, including NanosiRNA IFNAR and NanoManganese Radiotherapy Glioblastoma. The company was founded in 2003 and is based in Montpellier, France.
MEDESIS PHARMA SA EO 2- Financial Data Overview
| 0.33 | |
| 0.33 | |
| - | |
| 0.33 | |
| 0.33 | |
| 0.272-1.8 | |
| 2 034 K | |
| 4 960 K | |
| 300 K | |
| 0.033 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
MEDESIS PHARMA SA EO 2- Fundamental Data is available in our Financial Data APIs
- Net Revenue 300 K
- EBITDA -3 933 354
- Earnings Per Share -0.8
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get MEDESIS PHARMA SA EO 2- Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get MEDESIS PHARMA SA EO 2- End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
